Differential contribution of microglia and monocytes in neurodegenerative diseases
Open accessThe DOI matches its Crossref record; 123 of the 123 references it cites were found in a registry or an index.
Abstract
Neuroinflammation is a hallmark of neurodegenerative diseases including Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS). Microglia, the innate immune cells of the CNS, are the first to react to pathological insults. However, multiple studies have also demonstrated an involvement of peripheral monocytes in several neurodegenerative diseases. Due to the different origins of these two cell types, it is important to distinguish their role and function in the development and progression of these diseases. In this review, we will summarize and discuss the current knowledge of the differential contributions of microglia and monocytes in the common neurodegenerative diseases AD, PD, and ALS, as well as multiple sclerosis, which is now regarded as a combination of inflammatory processes and neurodegeneration. Until recently, it has been challenging to differentiate microglia from monocytes, as there were no specific markers. Therefore, the recent identification of specific molecular signatures of both cell types will help to advance our understanding of their differential contribution in neurodegenerative diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Monocyte and macrophage heterogeneity
Gordon, S., & Taylor, P. R. (2005) · Nature Reviews Immunology · doi:10.1038/nri1733 · Cited by 5,190 · cited 1×
“/CCR2lowCX3CR1high (Geiss- mann et al. 2003; Gordon and Taylor 2005; Woollard and Geissmann 2010).”
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M. F., Conway, S. J., Ng, L. G., Stanley, E. R., et al. (2010) · Science · doi:10.1126/science.1194637 · Cited by 5,175 · cited 2×
“5 during the murine CNS development (Ginhoux et al. 2010).”
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · cited 1×
“These include mutations in the superoxide dismutase 1 (SOD1) gene, which have been implicated in the origin of ALS, in the b-amyloid (Ab) precursor protein in AD, or in a-synuclein for PD (Goate et al. 1991; Rosen et al. 1993; Polymeropoulos et al. 1997).”
BackgroundAlzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343 · cited 1×
“Microglia are responsible for complement-mediated synaptic loss (Hong et al. 2016), which can be rescued by deleting complement factors C1q, C3, or CR3 in a mouse model of AD (Maier et al. 2008; Shi et al. 2017).”
BackgroundFate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
Yona, S., Kim, K.-W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams, M., Misharin, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.001 · Cited by 3,245 · cited 2×
“…such as transcrip- tomic profiles, proteomic signatures, and surface markers, to reduce the observation of artifacts arising from other myeloid cells (Gautier et al. 2012; Chiu et al. 2013; Goldmann et al. 2013; Parkhurst et al. 2013; Yona et al. 2013; Butovsky et al. 2014; Bennett et al. 2016).”
BackgroundTREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Monocyte recruitment during infection and inflammation
Shi, C., & Pamer, E. G. (2011) · Nature Reviews Immunology · doi:10.1038/nri3070 · Cited by 3,015 · cited 1×
“In the healthy body, these cells exist in parallel systems; however, during disease, their paths might cross (King et al. 2009; Shi and Pamer 2011).”
BackgroundMcGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979
Self-citationNLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice
Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.-C., et al. (2013) · Nature · doi:10.1038/nature11729 · Cited by 2,898 · cited 1×
“Among them, Heneka et al. (2013) described that reduction of IL-1b through deletion of the NLRP3 inflammasome decreased Ab and had a protective effect on memory.”
BackgroundJung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632 · cited 2×
“…(2017), Zrzavy et al. (2017) Arrows indicate changes in expression: : increased, ; decreased, ? unchanged development of the CX3CR1-CreERT mouse (Jung et al. 2000), which takes advantage of the longevity of microglia compared to peripheral monocytes, that also express CX3CR1, but renew within a…”
BackgroundMicroglia promote learning-dependent synapse formation through brain-derived neurotrophic factor
Parkhurst, C. N., Yang, G., Ninan, I., Savas, J. N., Yates, J. R., Lafaille, J. J., Hempstead, B. L., Littman, D. R., & Gan, W.-B. (2013) · Cell · doi:10.1016/j.cell.2013.11.030 · Cited by 2,599
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 1×
“…genes Triggering receptor expressed on myeloid cells 2 (TREM2), CD33, and complement receptor 1 (CR1) to be associated with an increased risk to develop AD (Bradshaw et al. 2013a, b; Guerreiro et al. 2013; Jonsson et al. 2013), shifting the focus on resident microglia and peripheral myeloid cells.”
BackgroundIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 6×
“On the other hand, they used the marker TMEM119, which is expressed on microglia, but not on infiltrating monocytes, to distin- guish phagocytic cells within the active lesion (Butovsky et al. 2014; Bennett et al. 2016; Satoh et al. 2016).”
BackgroundMethodInfluentialSelf-citationHashimoto, D., Chow, A., Noizat, C., Teo, P., Beasley, M. B., Leboeuf, M., Becker, C. D., See, P., Price, J., Lucas, D., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.004 · Cited by 2,311 · cited 1×
“As an alter- native to bone marrow chimeras, parabiosis, which allows for a shared blood circulation between two mice, can be used to distinguish resident microglia and peripheral monocytes (Hashimoto et al. 2013; Wang et al. 2016).”
The prevalence of Parkinson's disease: a systematic review and meta-analysis
Pringsheim, T., Jette, N., Frolkis, A., & Steeves, T. D. L. (2014) · Movement Disorders · doi:10.1002/mds.25945 · Cited by 2,188
Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment
Lavin, Y., Winter, D., Blecher-Gonen, R., David, E., Keren-Shaul, H., Merad, M., Jung, S., & Amit, I. (2014) · Cell · doi:10.1016/j.cell.2014.11.018 · Cited by 2,167
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144 · cited 1×
“In line with this, peripheral injections of LPS induced microgliosis and reduced tyrosine hydroxy- lase-positive neurons in the SN, illustrating that activation of microglia can indeed induce neurotoxicity in dopamin- ergic neurons (Qin et al. 2007; Bodea et al. 2014).”
BackgroundImmune attack: the role of inflammation in Alzheimer disease
Heppner, F. L., Ransohoff, R. M., & Becher, B. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3880 · Cited by 2,134 · cited 1×
“This functional impairment as well as their secretion of various pro-inflammatory cytokines in response to Ab (Vom Berg et al. 2012; Heppner et al. 2015; Wang et al. 2015a) led to the assumption that inhibition of the micro- glial reaction could ameliorate the pathology.”
BackgroundMonitoring of Blood Vessels and Tissues by a Population of Monocytes with Patrolling Behavior
Auffray, C., Fogg, D., Garfa, M., Elain, G., Join-Lambert, O., Kayal, S., Sarnacki, S., Cumano, A., Lauvau, G., & Geissmann, F. (2007) · Science · doi:10.1126/science.1142883 · Cited by 1,973
the Immunological Genome Consortium, Gautier, E. L., Shay, T., Miller, J., Greter, M., Jakubzick, C., Ivanov, S., Helft, J., Chow, A., Elpek, K. G., et al. (2012) · Nature Immunology · doi:10.1038/ni.2419 · Cited by 1,972 · cited 2×
“…such as transcrip- tomic profiles, proteomic signatures, and surface markers, to reduce the observation of artifacts arising from other myeloid cells (Gautier et al. 2012; Chiu et al. 2013; Goldmann et al. 2013; Parkhurst et al. 2013; Yona et al. 2013; Butovsky et al. 2014; Bennett et al. 2016).”
BackgroundNew tools for studying microglia in the mouse and human CNS
Bennett, M. L., Bennett, F. C., Liddelow, S. A., Ajami, B., Zamanian, J. L., Fernhoff, N. B., Mulinyawe, S. B., Bohlen, C. J., Adil, A., Tucker, A., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525528113 · Cited by 1,804
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
Miron, V. E., Boyd, A., Zhao, J.-W., Yuen, T. J., Ruckh, J. M., Shadrach, J. L., van Wijngaarden, P., Wagers, A. J., Williams, A., Franklin, R. J. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3469 · Cited by 1,777
Compston, A., & Coles, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08220-x · Cited by 1,743
Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
Zhang, B., Gaiteri, C., Bodea, L.-G., Wang, Z., McElwee, J., Podtelezhnikov, A. A., Zhang, C., Xie, T., Tran, L., Dobrin, R., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.030 · Cited by 1,657
Onset and Progression in Inherited ALS Determined by Motor Neurons and Microglia
Boillée, S., Yamanaka, K., Lobsiger, C. S., Copeland, N. G., Jenkins, N. A., Kassiotis, G., Kollias, G., & Cleveland, D. W. (2006) · Science · doi:10.1126/science.1123511 · Cited by 1,623
Depletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591 · cited 1×
“Hickman et al. (2013), Butovsky et al. (2014), Asai et al. (2015), Greenhalgh et al. (2016), Zrzavy et al. (2017) Neurodegenerative diseases Arg1: Apoe : Axl : Ccl2 : Cd45 : Clec7a : Gpnmb: Msr1: Spp1: Cd11b ?”
Self-citationThe P2Y12 receptor regulates microglial activation by extracellular nucleotides
Haynes, S. E., Hollopeter, G., Yang, G., Kurpius, D., Dailey, M. E., Gan, W.-B., & Julius, D. (2006) · Nature Neuroscience · doi:10.1038/nn1805 · Cited by 1,542 · cited 1×
“However, this molecule is down- regulated by reactive microglia as they can be found around amyloid plaques (Haynes et al. 2006; Krasemann et al. 2017).”
BackgroundControl of microglial neurotoxicity by the fractalkine receptor
Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531 · cited 1×
“Furthermore, mice lacking the frac- talkine receptor (CX3CR1), which is expressed by micro- glia and is important for microglia–neuron communication, show extensive neuronal loss in the toxin-induced MPTP PD mouse model (Cardona et al. 2006).”
BackgroundGosselin, D., Link, V. M., Romanoski, C. E., Fonseca, G. J., Eichenfield, D. Z., Spann, N. J., Stender, J. D., Chun, H. B., Garner, H., Geissmann, F., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.023 · Cited by 1,307
Inflammation in Neurodegenerative Disease—A Double-Edged Sword
Wyss-Coray, T., & Mucke, L. (2002) · Neuron · doi:10.1016/s0896-6273(02)00794-8 · Cited by 1,235
An environment-dependent transcriptional network specifies human microglia identity
Gosselin, D., Skola, D., Coufal, N. G., Holtman, I. R., Schlachetzki, J. C. M., Sajti, E., Jaeger, B. N., O’Connor, C., Fitzpatrick, C., Pasillas, M. P., et al. (2017) · Science · doi:10.1126/science.aal3222 · Cited by 1,220 · cited 1×
“Transcriptomic gene assays and computational biology, along with pro- teomic and epigenomic analysis, have provided unbiased insights into the contextual factors driving authentic, in vivo microglial reaction states (Gosselin et al. 2014; Matcovitch-Natan 2016; Gosselin et al. 2017).”
MethodIn vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
Gerhard, A., Pavese, N., Hotton, G., Turkheimer, F., Es, M., Hammers, A., Eggert, K., Oertel, W., Banati, R. B., & Brooks, D. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.08.002 · Cited by 1,200 · cited 1×
“In addition, positron emission tomography (PET) studies have shown that microgliosis is a prominent feature in PD brains (Gerhard et al. 2006; Bartels et al. 2010).”
BackgroundThe Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Microglia development follows a stepwise program to regulate brain homeostasis
Matcovitch-Natan, O., Winter, D. R., Giladi, A., Vargas Aguilar, S., Spinrad, A., Sarrazin, S., Ben-Yehuda, H., David, E., Zelada González, F., Perrin, P., et al. (2016) · Science · doi:10.1126/science.aad8670 · Cited by 1,180
Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions
Mildner, A., Schmidt, H., Nitsche, M., Merkler, D., Hanisch, U.-K., Mack, M., Heikenwalder, M., Brück, W., Priller, J., & Prinz, M. (2007) · Nature Neuroscience · doi:10.1038/nn2015 · Cited by 1,089 · cited 6×
“…receptor CCR2 is critical for the accumulation of Ly6Chigh/CCR2high mono- cytes in the CNS. CCR2 and its ligand CCL2 play an important role in regulating Ly6Chigh/CCR2? monocyte infiltration to the CNS and facilitate tissue damage in MS and EAE (Mildner et al. 2007, 2009; King et al. 2009).”
BackgroundInfluentialInfiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool
Ajami, B., Bennett, J. L., Krieger, C., McNagny, K. M., & Rossi, F. M. V. (2011) · Nature Neuroscience · doi:10.1038/nn.2887 · Cited by 1,061 · cited 2×
“Either their appearance in the CNS is just transient (Ajami et al. 2011) or they could be reprogrammed by their new environment and become more like microglia, making them harder to distinguish (Gosselin et al. 2014; Lavin et al. 2014; Varvel et al. 2015).”
BackgroundProgressive multiple sclerosis: pathology and pathogenesis
Lassmann, H., van Horssen, J., & Mahad, D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.168 · Cited by 1,033 · cited 5×
“In addition, this review will also cover multiple sclerosis (MS), which has long been considered primarily an autoimmune disease (Lassmann et al. 2012).”
BackgroundInfluentialGold, R. (2006) · Brain · doi:10.1093/brain/awl075 · Cited by 1,017 · cited 1×
“Extrapolation of data from EAE studies translating to MS clinical trials has only been partially successful (Gold et al. 2006, Aharoni 2013), which could be in part to the inflammatory process in MS being driven by other immune cells (Cardona et al. 2008, Lassmann et al. 2012, Croxford et al. 2015).”
Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
Griciuc, A., Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. H., Hyman, B. T., & Tanzi, R. E. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.014 · Cited by 1,004
Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90746-3 · Cited by 986
Butovsky, O., Ziv, Y., Schwartz, A., Landa, G., Talpalar, A. E., Pluchino, S., Martino, G., & Schwartz, M. (2006) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.10.006 · Cited by 923
Self-citationRecent global trends in the prevalence and incidence of dementia, and survival with dementia
Prince, M., Ali, G.-C., Guerchet, M., Prina, A. M., Albanese, E., & Wu, Y.-T. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0188-8 · Cited by 876
Differential roles of microglia and monocytes in the inflamed central nervous system
Yamasaki, R., Lu, H., Butovsky, O., Ohno, N., Rietsch, A. M., Cialic, R., Wu, P. M., Doykan, C. E., Lin, J., Cotleur, A. C., et al. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20132477 · Cited by 856
Self-citationMogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M., & Nagatsu, T. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90508-8 · Cited by 855 · cited 1×
“Immune system involvement in PD was demonstrated by the observation of elevated pro-inflammatory mediators (TNFa, IL1b, and IL6) in the CSF and brains of PD patients (Mogi et al. 1994a, b).”
BackgroundTREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
Wang, Y., Ulland, T. K., Ulrich, J. D., Song, W., Tzaferis, J. A., Hole, J. T., Yuan, P., Mahan, T. E., Shi, Y., Gilfillan, S., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151948 · Cited by 840 · cited 3×
“As discussed above, Wang et al. (2016) distinguished micro- glia and monocytes by parabiosis of mice expressing either CD45.”
BackgroundYuan, P., Condello, C., Keene, C. D., Wang, Y., Bird, T. D., Paul, S. M., Luo, W., Colonna, M., Baddeley, D., & Grutzendler, J. (2016) · Neuron · doi:10.1016/j.neuron.2016.05.003 · Cited by 817
Minocycline selectively inhibits M1 polarization of microglia
Kobayashi, K., Imagama, S., Ohgomori, T., Hirano, K., Uchimura, K., Sakamoto, K., Hirakawa, A., Takeuchi, H., Suzumura, A., Ishiguro, N., et al. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.54 · Cited by 742
Turner, M. R., Cagnin, A., Turkheimer, F. E., Miller, C. C. J., Shaw, C. E., Brooks, D. J., Leigh, P. N., & Banati, R. B. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.012 · Cited by 737 · cited 1×
“…neuroinflammatory reaction (McGeer et al. 1991; Kawamata et al. 1992; Engelhardt et al. 1993; Hall et al. 1998; Alexianu et al. 2001; McGeer and McGeer 2002), which includes prolif- eration of resident microglia (Henkel et al. 2004; Turner et al. 2004; Solomon et al. 2006; Appel et al. 2011).”
BackgroundExperimental autoimmune encephalomyelitis repressed by microglial paralysis
Heppner, F. L., Greter, M., Marino, D., Falsig, J., Raivich, G., Hövelmeyer, N., Waisman, A., Rülicke, T., Prinz, M., Priller, J., et al. (2005) · Nature Medicine · doi:10.1038/nm1177 · Cited by 732 · cited 13×
“A study using the CCR2RFP–CX3CR1GFP mouse model demonstrated distinct roles for microglia and infiltrating monocytes during EAE.”
MethodInfluentialDystrophic microglia in the aging human brain
Streit, W. J., Sammons, N. W., Kuhns, A. J., & Sparks, D. L. (2004) · Glia · doi:10.1002/glia.10319 · Cited by 705 · cited 1×
“This might be because they are impaired in their phagocytic function by the presence of Ab, chronic inflammation, or an age-linked dysfunction (Streit et al. 2004; Hickman et al. 2013; Krabbe et al. 2013).”
BackgroundSpangenberg, E. E., Lee, R. J., Najafi, A. R., Rice, R. A., Elmore, M. R. P., Blurton-Jones, M., West, B. L., & Green, K. N. (2016) · Brain · doi:10.1093/brain/aww016 · Cited by 695
A new type of microglia gene targeting shows TAK1 to be pivotal in CNS autoimmune inflammation
Goldmann, T., Wieghofer, P., Müller, P. F., Wolf, Y., Varol, D., Yona, S., Brendecke, S. M., Kierdorf, K., Staszewski, O., Datta, M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3531 · Cited by 688
Loss of ‘homeostatic’ microglia and patterns of their activation in active multiple sclerosis
Zrzavy, T., Hametner, S., Wimmer, I., Butovsky, O., Weiner, H. L., & Lassmann, H. (2017) · Brain · doi:10.1093/brain/awx113 · Cited by 684 · cited 5×
“Hickman et al. (2013), Butovsky et al. (2014), Asai et al. (2015), Greenhalgh et al. (2016), Zrzavy et al. (2017) Neurodegenerative diseases Arg1: Apoe : Axl : Ccl2 : Cd45 : Clec7a : Gpnmb: Msr1: Spp1: Cd11b ?”
BackgroundInfluentialSelf-citationPaloneva, J., Manninen, T., Christman, G., Hovanes, K., Mandelin, J., Adolfsson, R., Bianchin, M., Bird, T., Miranda, R., Salmaggi, A., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342259 · Cited by 683 · cited 1×
“Homozygous mutations in TREM2, a myeloid cell-sur- face receptor which is also implicated in AD, lead to demyelination and early onset dementia in humans (Palo- neva et al. 2002).”
BackgroundJay, T. R., Miller, C. M., Cheng, P. J., Graham, L. C., Bemiller, S., Broihier, M. L., Xu, G., Margevicius, D., Karlo, J. C., Sousa, G. L., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142322 · Cited by 682 · cited 4×
“On one hand, they demonstrate that the homeostatic microglia marker P2Y12 is lost in active MS lesions, but reappears in inactive lesions.”
BackgroundInfluentialSelf-citationHeterogeneity of CNS myeloid cells and their roles in neurodegeneration
Prinz, M., Priller, J., Sisodia, S. S., & Ransohoff, R. M. (2011) · Nature Neuroscience · doi:10.1038/nn.2923 · Cited by 674 · cited 4×
“Moreover, deletion of SOD1 transgene within CD11b? myeloid cells (Boillee et al. 2006; Wang et al. 2009) improves survival in SOD1 mice.”
BackgroundInfluentialMicroglia Induce Motor Neuron Death via the Classical NF-κB Pathway in Amyotrophic Lateral Sclerosis
Frakes, A. E., Ferraiuolo, L., Haidet-Phillips, A. M., Schmelzer, L., Braun, L., Miranda, C. J., Ladner, K. J., Bevan, A. K., Foust, K. D., Godbout, J. P., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.01.013 · Cited by 638 · cited 1×
“Consistent with these findings, inhibition of NF-jB suppresses the neuroinflammatory component of microglial toxicity in co-cultured motor neurons (Frakes et al. 2014), and deletion of galectin-3 exacerbates microglial activation and accelerates disease progression in SOD1 mice (Lerman et al. 2012).”
ResultHoltman, I. R., Raj, D. D., Miller, J. A., Schaafsma, W., Yin, Z., Brouwer, N., Wes, P. D., Möller, T., Orre, M., Kamphuis, W., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0203-5 · Cited by 619 · cited 1×
“Csf1r; P2ry12 ; Siglec-H ; Sall1 ; Tgfbr; Chiu et al. (2013), Holtman et al. (2015), Keren-Shaul (2017), Krasemann (2017), Zrzavy et al. (2017) Arrows indicate changes in expression: : increased, ; decreased, ? unchanged development of the CX3CR1-CreERT mouse (Jung et al. 2000), which takes…”
Saederup, N., Cardona, A. E., Croft, K., Mizutani, M., Cotleur, A. C., Tsou, C.-L., Ransohoff, R. M., & Charo, I. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013693 · Cited by 599 · cited 2×
“In EAE, monocytes that are recruited to the CNS are CCR2high/CX3CR1low (Saederup et al. 2010; Garcia et al. 2013), further distinguishing them from resident microglia.”
BackgroundInefficient clearance of myelin debris by microglia impairs remyelinating processes
Lampron, A., Larochelle, A., Laflamme, N., Préfontaine, P., Plante, M.-M., Sánchez, M. G., Yong, V. W., Stys, P. K., Tremblay, M.-È., & Rivest, S. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20141656 · Cited by 595 · cited 1×
“However, microglia also can be neuroprotective and promote CNS repair by the clearance of inhibitory myelin debris (Miron et al. 2013; Lampron et al. 2015).”
BackgroundComplement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice
Shi, Q., Chowdhury, S., Ma, R., Le, K. X., Hong, S., Caldarone, B. J., Stevens, B., & Lemere, C. A. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6295 · Cited by 593 · cited 1×
“Microglia are responsible for complement-mediated synaptic loss (Hong et al. 2016), which can be rescued by deleting complement factors C1q, C3, or CR3 in a mouse model of AD (Maier et al. 2008; Shi et al. 2017).”
BackgroundApolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
Atagi, Y., Liu, C.-C., Painter, M. M., Chen, X.-F., Verbeeck, C., Zheng, H., Li, X., Rademakers, R., Kang, S. S., Xu, H., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.679043 · Cited by 587 · cited 1×
“TREM2 is a transmembrane glycoprotein that binds phospholipids present in the brain due to neu- ronal cell death or myelin damage (Wang et al. 2015b) and has been shown to bind ApoE (Apolipoprotein E) (Atagi et al. 2015), whose isoform e4 is a major risk factor for AD (Corder et al. 1993).”
BackgroundCD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
Initiative, T. A. D. N., Bradshaw, E. M., Chibnik, L. B., Keenan, B. T., Ottoboni, L., Raj, T., Tang, A., Rosenkrantz, L. L., Imboywa, S., Lee, M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3435 · Cited by 570 · cited 3×
“…found that TREM2 expression is increased in monocytes from carriers with the CD33 risk allele and that CD33 expression itself is increased on microglia in human AD brains, and elevated levels of CD33 inhibited microglial uptake and phagocytosis of Ab (Bradshaw et al. 2013a, b; Griciuc et al. 2013).”
BackgroundSall1 is a transcriptional regulator defining microglia identity and function
Buttgereit, A., Lelios, I., Yu, X., Vrohlings, M., Krakoski, N. R., Gautier, E. L., Nishinakamura, R., Becher, B., & Greter, M. (2016) · Nature Immunology · doi:10.1038/ni.3585 · Cited by 570
C9orf72 is required for proper macrophage and microglial function in mice
O’Rourke, J. G., Bogdanik, L., Yáñez, A., Lall, D., Wolf, A. J., Muhammad, A. K. M. G., Ho, R., Carmona, S., Vit, J. P., Zarrow, J., et al. (2016) · Science · doi:10.1126/science.aaf1064 · Cited by 550
Olmos-Alonso, A., Schetters, S. T. T., Sri, S., Askew, K., Mancuso, R., Vargas-Caballero, M., Holscher, C., Perry, V. H., & Gomez-Nicola, D. (2016) · Brain · doi:10.1093/brain/awv379 · Cited by 532
TREM2 sustains microglial expansion during aging and response to demyelination
Poliani, P. L., Wang, Y., Fontana, E., Robinette, M. L., Yamanishi, Y., Gilfillan, S., & Colonna, M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77983 · Cited by 525 · cited 1×
“In the cuprizone-induced mouse model of demyelination, Trem2 deficiency rendered microglia defective in clearing myelin debris, which resulted in a persistent demyelination (Cantoni et al. 2015; Poliani et al. 2015).”
BackgroundDagher, N. N., Najafi, A. R., Kayala, K. M. N., Elmore, M. R. P., White, T. E., Medeiros, R., West, B. L., & Green, K. N. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0366-9 · Cited by 505 · cited 1×
“Secondly, treatment of AD mice with a CSF1-re- ceptor antagonist to deplete microglia (PLX3397 or GW2580) reduced neuronal loss and improved cognition, but did not affect amyloid-plaque burden (Dagher et al. 2015; Olmos-Alonso et al. 2016; Spangenberg et al. 2016).”
BackgroundIntrathecal inflammation precedes development of Alzheimer's disease
Tarkowski, E. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.9.1200 · Cited by 501 · cited 1×
“…cytokine levels are found in the CSF of individuals with mild cog- nitive impairment—amnestic type (MCI), who have an increased risk to develop AD, suggesting that this neu- roinflammation occurs early in the disease development and might trigger AD (Tarkowski et al. 2003; Brosseron et al. 2014).”
BackgroundThe Cytokine GM-CSF Drives the Inflammatory Signature of CCR2+ Monocytes and Licenses Autoimmunity
Croxford, A. L., Lanzinger, M., Hartmann, F. J., Schreiner, B., Mair, F., Pelczar, P., Clausen, B. E., Jung, S., Greter, M., & Becher, B. (2015) · Immunity · doi:10.1016/j.immuni.2015.08.010 · Cited by 484
Pramatarova, A., Laganière, J., Roussel, J., Brisebois, K., & Rouleau, G. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-10-03369.2001 · Cited by 482 · cited 2×
“Indeed, restricted expression of SOD1 mutations to neurons is not sufficient to induce ALS pathology (Pramatarova et al. 2001; Lino et al. 2002); however, wild-type neurons acquire an ALS phenotype when surrounded by glial cells carrying the SOD1 mutation (Clement et al. 2003).”
BackgroundModulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS
Butovsky, O., Siddiqui, S., Gabriely, G., Lanser, A. J., Dake, B., Murugaiyan, G., Doykan, C. E., Wu, P. M., Gali, R. R., Iyer, L. K., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62636 · Cited by 481
Self-citationMacrophages in inflammatory multiple sclerosis lesions have an intermediate activation status
Vogel, D. Y., Vereyken, E. J., Glim, J. E., Heijnen, P. D., Moeton, M., van der Valk, P., Amor, S., Teunissen, C. E., van Horssen, J., & Dijkstra, C. D. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-35 · Cited by 479
Krabbe, G., Halle, A., Matyash, V., Rinnenthal, J. L., Eom, G. D., Bernhardt, U., Miller, K. R., Prokop, S., Kettenmann, H., & Heppner, F. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060921 · Cited by 478 · cited 1×
“This might be because they are impaired in their phagocytic function by the presence of Ab, chronic inflammation, or an age-linked dysfunction (Streit et al. 2004; Hickman et al. 2013; Krabbe et al. 2013).”
BackgroundInflammatory processes in amyotrophic lateral sclerosis
McGeer, P. L., & McGeer, E. G. (2002) · Muscle & Nerve · doi:10.1002/mus.10191 · Cited by 470 · cited 3×
“reaction (McGeer et al. 1991; Kawamata et al. 1992; Engelhardt et al. 1993; Hall et al. 1998; Alexianu et al. 2001; McGeer and McGeer 2002), which includes proliferation of resident microglia (Henkel et al.”
BackgroundDisease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease
Jay, T. R., Hirsch, A. M., Broihier, M. L., Miller, C. M., Neilson, L. E., Ransohoff, R. M., Lamb, B. T., & Landreth, G. E. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2110-16.2016 · Cited by 457
Brosseron, F., Krauthausen, M., Kummer, M., & Heneka, M. T. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8657-1 · Cited by 447
Mildner, A., Mack, M., Schmidt, H., Brück, W., Djukic, M., Zabel, M. D., Hille, A., Priller, J., & Prinz, M. (2009) · Brain · doi:10.1093/brain/awp144 · Cited by 445 · cited 14×
“A study using the CCR2RFP–CX3CR1GFP mouse model demonstrated distinct roles for microglia and infiltrating monocytes during EAE.”
BackgroundInfluentialKing, I. L., Dickendesher, T. L., & Segal, B. M. (2009) · Blood · doi:10.1182/blood-2008-07-168575 · Cited by 444
Oligodendrocyte‐microglia cross‐talk in the central nervous system
Peferoen, L., Kipp, M., van der Valk, P., van Noort, J. M., & Amor, S. (2014) · Immunology · doi:10.1111/imm.12163 · Cited by 438 · cited 1×
“Once microglia are activated, they can damage other CNS cells, in particular oligodendrocytes and neu- rons (Butovsky et al. 2006a, b; Peferoen et al. 2014).”
BackgroundTMEM119 marks a subset of microglia in the human brain
Satoh, J., Kino, Y., Asahina, N., Takitani, M., Miyoshi, J., Ishida, T., & Saito, Y. (2016) · Neuropathology · doi:10.1111/neup.12235 · Cited by 434
Lino, M. M., Schneider, C., & Caroni, P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-12-04825.2002 · Cited by 424
Microglial cell activation and proliferation precedes the onset of CNS autoimmunity
Ponomarev, E. D., Shriver, L. P., Maresz, K., & Dittel, B. N. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20488 · Cited by 420
Inhibition of IL-12/IL-23 signaling reduces Alzheimer's disease–like pathology and cognitive decline
vom Berg, J., Prokop, S., Miller, K. R., Obst, J., Kälin, R. E., Lopategui-Cabezas, I., Wegner, A., Mair, F., Schipke, C. G., Peters, O., et al. (2012) · Nature Medicine · doi:10.1038/nm.2965 · Cited by 416
Formation and maintenance of Alzheimer's disease β-amyloid plaques in the absence of microglia
Grathwohl, S. A., Kälin, R. E., Bolmont, T., Prokop, S., Winkelmann, G., Kaeser, S. A., Odenthal, J., Radde, R., Eldh, T., Gandy, S., et al. (2009) · Nature Neuroscience · doi:10.1038/nn.2432 · Cited by 401
Il10 Deficiency Rebalances Innate Immunity to Mitigate Alzheimer-Like Pathology
Guillot-Sestier, M.-V., Doty, K. R., Gate, D., Rodriguez, J., Leung, B. P., Rezai-Zadeh, K., & Town, T. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.068 · Cited by 363
Targeting mi R‐155 restores abnormal microglia and attenuates disease in SOD 1 mice
Butovsky, O., Jedrychowski, M. P., Cialic, R., Krasemann, S., Murugaiyan, G., Fanek, Z., Greco, D. J., Wu, P. M., Doykan, C. E., Kiner, O., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24304 · Cited by 358 · cited 2×
“Studies in ALS patients have found that peripheral monocytes are functionally altered (Zhang et al. 2005, 2006; Nardo et al. 2011), skewed towards a pro- inflammatory state (Butovsky et al. 2015; Zhao et al. 2017), and can invade the CNS (Zondler 2016).”
BackgroundSelf-citationMikita, J., Dubourdieu-Cassagno, N., Deloire, M. S., Vekris, A., Biran, M., Raffard, G., Brochet, B., Canron, M.-H., Franconi, J.-M., Boiziau, C., et al. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458510379243 · Cited by 358 · cited 1×
“Myeloid cells, particularly monocytes, infiltrate the CNS in the early stages of EAE development and contribute to the inflammatory response and clinical disease (Ajami et al. 2011; Mikita et al. 2011).”
BackgroundMyelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis
Boven, L. A., Van Meurs, M., Van Zwam, M., Wierenga-Wolf, A., Hintzen, R. Q., Boot, R. G., Aerts, J. M., Amor, S., Nieuwenhuis, E. E., & Laman, J. D. (2006) · Brain · doi:10.1093/brain/awh707 · Cited by 353 · cited 1×
“Microglia in MS contain myelin and axonal debris, present higher expression of MHC class II and co-stimulatory molecules, and secrete different inflammatory and neuro- toxic mediators in lesions (Boven et al. 2006; Butovsky et al. 2006a, b; Huizinga et al. 2012; Vogel et al. 2013).”
BackgroundA novel Ly6C/Ly6G‐based strategy to analyze the mouse splenic myeloid compartment
Rose, S., Misharin, A., & Perlman, H. (2012) · Cytometry Part A · doi:10.1002/cyto.a.22012 · Cited by 347 · cited 2×
“Ly6chigh Ly6gneg Mildner et al. (2007, 2009), Ingersoll et al. (2010), Butovsky et al. (2012), Rose et al. (2012), Asai et al. (2014) Patrolling Ccr2low Cd11a?”
Chakrabarty, P., Jansen‐West, K., Beccard, A., Ceballos‐Diaz, C., Levites, Y., Verbeeck, C., Zubair, A. C., Dickson, D., Golde, T. E., & Das, P. (2010) · The FASEB Journal · doi:10.1096/fj.09-141754 · Cited by 328
Maier, M., Peng, Y., Jiang, L., Seabrook, T. J., Carroll, M. C., & Lemere, C. A. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.0829-08.2008 · Cited by 323 · cited 1×
“Microglia are responsible for complement-mediated synaptic loss (Hong et al. 2016), which can be rescued by deleting complement factors C1q, C3, or CR3 in a mouse model of AD (Maier et al. 2008; Shi et al. 2017).”
BackgroundLymphocytic Infiltrates in the Spinal Cord in Amyotrophic Lateral Sclerosis
Engelhardt, J. I., Tajti, J., & Appel, S. H. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540010026013 · Cited by 318 · cited 2×
“reaction (McGeer et al. 1991; Kawamata et al. 1992; Engelhardt et al. 1993; Hall et al. 1998; Alexianu et al. 2001; McGeer and McGeer 2002), which includes proliferation of resident microglia (Henkel et al.”
BackgroundBrodacki, B., Staszewski, J., Toczyłowska, B., Kozłowska, E., Drela, N., Chalimoniuk, M., & Stępien, A. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.06.040 · Cited by 316 · cited 1×
“In addition to investigating the role of microglia, there have also been several efforts to study the peripheral immune system in PD. Elevated serum levels of cytokines (IL-6, IL-10, TNFa, and IFNc) have been reported in peripheral blood from PD patients (Brodacki et al. 2008; Reale et al. 2009).”
BackgroundTREM2 regulates microglial cell activation in response to demyelination in vivo
Cantoni, C., Bollman, B., Licastro, D., Xie, M., Mikesell, R., Schmidt, R., Yuede, C. M., Galimberti, D., Olivecrona, G., Klein, R. S., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1388-1 · Cited by 296 · cited 1×
“In the cuprizone-induced mouse model of demyelination, Trem2 deficiency rendered microglia defective in clearing myelin debris, which resulted in a persistent demyelination (Cantoni et al. 2015; Poliani et al. 2015).”
BackgroundInflammatory dysregulation of blood monocytes in Parkinson’s disease patients
Grozdanov, V., Bliederhaeuser, C., Ruf, W. P., Roth, V., Fundel-Clemens, K., Zondler, L., Brenner, D., Martin-Villalba, A., Hengerer, B., Kassubek, J., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1345-4 · Cited by 295 · cited 1×
“In addition, monocytes from PD patients display a distinct transcriptome signature, have an elevated inflammatory profile, and are ‘‘hyper-re- sponsive’’ to LPS stimulation in comparison to healthy controls (Grozdanov et al. 2014).”
BackgroundLRRK2 levels in immune cells are increased in Parkinson’s disease
Cook, D. A., Kannarkat, G. T., Cintron, A. F., Butkovich, L. M., Fraser, K. B., Chang, J., Grigoryan, N., Factor, S. A., West, A. B., Boss, J. M., et al. (2017) · npj Parkinson's Disease · doi:10.1038/s41531-017-0010-8 · Cited by 279 · cited 1×
“The increased LRRK2 expression level positively correlates with the frequency of inflammatory monocytes from PD patients (Cook et al. 2017).”
BackgroundMicroglia Versus Myeloid Cell Nomenclature during Brain Inflammation
Greter, M., Lelios, I., & Croxford, A. L. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00249 · Cited by 273 · cited 1×
“Many of the find- ings in the past few decades are based on markers that are expressed by both peripheral monocytes and microglia (i.e., Iba1, CD45, and CD11b) (Prinz et al. 2011; Greter et al. 2015).”
BackgroundSuárez-Calvet, M., Araque Caballero, M. Á., Kleinberger, G., Bateman, R. J., Fagan, A. M., Morris, J. C., Levin, J., Danek, A., Ewers, M., Haass, C., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aag1767 · Cited by 272 · cited 1×
“…recent study analyzing sol- uble TREM2 (sTREM2) in the CSF of patients with different disease stages of AD, from preclinical to dementia stages, revealed that sTREM2 is already upregulated in the early stages of the disease and is associated with neuronal injury markers (Suarez-Calvet et al. 2016).”
BackgroundLoss-of-function mutations in the C9ORF72 mouse ortholog cause fatal autoimmune disease
Burberry, A., Suzuki, N., Wang, J.-Y., Moccia, R., Mordes, D. A., Stewart, M. H., Suzuki-Uematsu, S., Ghosh, S., Singh, A., Merkle, F. T., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6038 · Cited by 269
Atanasio, A., Decman, V., White, D., Ramos, M., Ikiz, B., Lee, H.-C., Siao, C.-J., Brydges, S., LaRosa, E., Bai, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep23204 · Cited by 263
Butovsky, O. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26836 · Cited by 261 · cited 3×
“Microglia in MS contain myelin and axonal debris, present higher expression of MHC class II and co-stimulatory molecules, and secrete different inflammatory and neuro- toxic mediators in lesions (Boven et al. 2006; Butovsky et al. 2006a, b; Huizinga et al. 2012; Vogel et al. 2013).”
BackgroundSelf-citationReal-Time In Vivo Imaging Reveals the Ability of Monocytes to Clear Vascular Amyloid Beta
Michaud, J.-P., Bellavance, M.-A., Préfontaine, P., & Rivest, S. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.10.010 · Cited by 257
Sanchez-Guajardo, V., Febbraro, F., Kirik, D., & Romero-Ramos, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008784 · Cited by 256 · cited 1×
“Reactive microglia have also been detected in the SN in toxin-induced as well as transgenic mouse models for PD (Czlonkowska et al. 1996; Sanchez-Guajardo et al. 2010; Hoenen et al. 2016).”
BackgroundNeurodegeneration by Activation of the Microglial Complement-Phagosome Pathway
Bodea, L.-G., Wang, Y., Linnartz-Gerlach, B., Kopatz, J., Sinkkonen, L., Musgrove, R., Kaoma, T., Muller, A., Vallar, L., Di Monte, D. A., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.5002-13.2014 · Cited by 234
IgG Reactivity in the Spinal Cord and Motor Cortex in Amyotrophic Lateral Sclerosis
Engelhardt, J. I., & Appel, S. H. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530110068019 · Cited by 221
Mechanisms of white matter damage in multiple sclerosis
Lassmann, H. (2014) · Glia · doi:10.1002/glia.22597 · Cited by 191 · cited 1×
“This active demyelination and neurodegeneration is also associated with reactive microgliosis (Lassmann 2014).”
BackgroundMutant SOD1G93A microglia are more neurotoxic relative to wild‐type microglia
Xiao, Q., Zhao, W., Beers, D. R., Yen, A. A., Xie, W., Henkel, J. S., & Appel, S. H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04677.x · Cited by 174 · cited 1×
“…(Kobayashi et al. 2013), produce excessive reactive oxidative species (Har- raz et al. 2008), and exhibit enhanced neurotoxicity after LPS treatment (Xiao et al. 2007) and in late phases of the disease (Liao et al. 2012), supporting the concept that microgliosis contributes to motor neuron…”
BackgroundCD33 modulates TREM2: convergence of Alzheimer loci
Chan, G., White, C. C., Winn, P. A., Cimpean, M., Replogle, J. M., Glick, L. R., Cuerdon, N. E., Ryan, K. J., Johnson, K. A., Schneider, J. A., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4126 · Cited by 162
Preactive lesions in multiple sclerosis
van der Valk, P., & Amor, S. (2009) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32832b4c76 · Cited by 156 · cited 1×
“Earlier studies have described that reactive microglia are present at early and late stages of disease (van der Valk and Amor 2009; Singh et al. 2013).”
BackgroundPeripheral monocytes are functionally altered and invade the CNS in ALS patients
Zondler, L., Müller, K., Khalaji, S., Bliederhäuser, C., Ruf, W. P., Grozdanov, V., Thiemann, M., Fundel-Clemes, K., Freischmidt, A., Holzmann, K., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1548-y · Cited by 154
Gravel, M., Béland, L.-C., Soucy, G., Abdelhamid, E., Rahimian, R., Gravel, C., & Kriz, J. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.0854-15.2016 · Cited by 117
Impact of peripheral myeloid cells on amyloid-β pathology in Alzheimer’s disease–like mice
Prokop, S., Miller, K. R., Drost, N., Handrick, S., Mathur, V., Luo, J., Wegner, A., Wyss-Coray, T., & Heppner, F. L. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150479 · Cited by 116 · cited 1×
“The approach of a transient depletion of resident microglia using an inducible suicide gene and their subsequent replacement with peripheral myeloid cells did not have any impact on Ab plaque burden or APP processing (Prokop et al. 2015; Varvel et al. 2015).”
BackgroundSolomon, J. N., Lewis, C. B., Ajami, B., Corbel, S. Y., Rossi, F. M. V., & Krieger, C. (2006) · Glia · doi:10.1002/glia.20331 · Cited by 105
Varvel, N. H., Grathwohl, S. A., Degenhardt, K., Resch, C., Bosch, A., Jucker, M., & Neher, J. J. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150478 · Cited by 99
Peripheral Chemo-Cytokine Profiles in Alzheimers and Parkinsons Diseases
Reale, M., Greig, N., & Kamal, M. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709789055199 · Cited by 82 · cited 1×
“In addition to investigating the role of microglia, there have also been several efforts to study the peripheral immune system in PD. Elevated serum levels of cytokines (IL-6, IL-10, TNFa, and IFNc) have been reported in peripheral blood from PD patients (Brodacki et al. 2008; Reale et al. 2009).”
BackgroundGowing, G., Lalancette-Hébert, M., Audet, J.-N., Dequen, F., & Julien, J.-P. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.08.021 · Cited by 53 · cited 1×
“Others studies have shown the importance of CSF1R signaling in microglia and its contribution to neu- rodegeneration in SOD1 models (Gowing et al. 2009; Martinez-Muriana et al. 2016).”
BackgroundThe Role of LRRK2 in the Regulation of Monocyte Adhesion to Endothelial Cells
Hongge, L., Kexin, G., Xiaojie, M., Nian, X., & Jinsha, H. (2015) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0312-9 · Cited by 36 · cited 1×
“Like- wise, LRRK2 expression is seen to be increased by pro- inflammatory mediators like IL-1b, TNFa, and IFN-c (Gardet et al. 2010; Hongge et al. 2015).”
Background
Cited by
Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes
Kwon, H. S., & Koh, S.-H. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00221-2 · Cited by 2,595
Neuroinflammatory Markers: Key Indicators in the Pathology of Neurodegenerative Diseases
Rauf, A., Badoni, H., Abu-Izneid, T., Olatunde, A., Rahman, M. M., Painuli, S., Semwal, P., Wilairatana, P., & Mubarak, M. S. (2022) · Molecules · doi:10.3390/molecules27103194 · Cited by 306
RetractedMicroglia and monocytes in inflammatory CNS disease: integrating phenotype and function
Spiteri, A. G., Wishart, C. L., Pamphlett, R., Locatelli, G., & King, N. J. C. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02384-2 · Cited by 244
“Microglia are also joined by a substantial infiltrate of BM-derived monocytes [298], both of which similarly express typical myeloid markers [19, 204, 298, 299, 332] (such as CD68, Fig.”
BackgroundRonning, K. E., Karlen, S. J., Miller, E. B., & Burns, M. E. (2019) · Scientific Reports · doi:10.1038/s41598-019-41141-0 · Cited by 88
Dionisie, V., Filip, G. A., Manea, M. C., Movileanu, R. C., Moisa, E., Manea, M., Riga, S., & Ciobanu, A. M. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10091924 · Cited by 82
Metadata
- Authors
- Baufeld, C., O’Loughlin, E., Calcagno, N., Madore, C., & Butovsky, O.
- Venue
- Journal of Neural Transmission
- Published
- 2017-10-23
- Volume
- 125
- Issue
- 5
- Pages
- 809-826
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2766931716
- Cited by
- 123
- References
- 123
- FWCI
- 3.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.